Ferrara, Italy

Romeo Romagnoli

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Milan, IT (2003)
  • Ferrara, IT (2000 - 2016)

Company Filing History:


Years Active: 2000-2025

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Romeo Romagnoli

Introduction

Romeo Romagnoli is a distinguished inventor based in Ferrara, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-cancer compounds. With a total of 11 patents to his name, Romagnoli's work has the potential to impact cancer treatment significantly.

Latest Patents

Among his latest patents are innovative compounds related to thioridazine derivatives. These compounds are particularly suitable for the treatment of pediatric acute myeloid leukemia, specifically targeting the KMT2A/AFDN rearrangement. Additionally, he has developed anti-cancer compounds that exhibit cytostatic activity against tumor cells, showcasing his commitment to advancing cancer therapies.

Career Highlights

Throughout his career, Romagnoli has worked with notable companies such as King Pharmaceuticals Research and Development, Inc. and Pharmacia & Upjohn S.p.a. His experience in these organizations has allowed him to refine his expertise in pharmaceutical research and development.

Collaborations

Romagnoli has collaborated with esteemed colleagues, including Pier Giovanni Baraldi and Paolo Cozzi. These partnerships have fostered a collaborative environment that enhances the innovation process in their research endeavors.

Conclusion

Romeo Romagnoli's contributions to the field of pharmaceuticals, particularly in cancer treatment, highlight his role as a leading inventor. His innovative patents and collaborations reflect his dedication to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…